Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa
Clinical trial NCT03799627 · COMPLETED
Trial details
- NCT number
- NCT03799627
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-31
- Primary completion
- 2020-06-05
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.